Prosiectau (583)
Cardiff University Schools involved in this Project
Drug eluting ureteral stents (01.07.2011 - 01.07.2014)
- Allender, Christopher
S PHRMY ESF BAILL KESS (01.07.2011 - 31.07.2015)
- Baillie, Les
S PHRMY ESF WHITE KESS (01.07.2011 - 31.07.2015)
- White, Alex
Testing of the sporicidal activity of PDI wipe against clostridium difficile (01.08.2011 - 14.08.2011)
- Maillard, Jean-Yves
Bacterial resistance to biocides: An assessment of resistance mechanisms and method development (01.10.2011 - 30.09.2015)
- Maillard, Jean-Yves
Caveolin-1 is a key determinant of the stem-like features of RCC (01.10.2011 - 31.12.2014)
- Gumbleton, Mark
Exploration of CD44 as a mediator of a drug resistant phenotype in breast cancer (01.10.2011 - 30.09.2014)
- Hiscox, Stephen
FAK as a novel therapeutic target in endocrine-resistant and endocrine-sensitive breast cancer (01.10.2011 - 30.09.2014)
- Hiscox, Stephen
Revision of the methodology used for systematic mapping of the HTA systems in Europe (01.10.2011 - 30.09.2014)
Synthetic routes of 18F labelled gemicitabine and related 2"-fluoronucleotides (01.10.2011 - 30.09.2014)
- Westwell, Andrew
Determination of human exposure to naturally-occurring B.anthracis (01.11.2011 - 31.01.2013)
- Baillie, Les
Development of affinity measurements to enhance the commercialisation of an antibody to treat Alzheimer's disease (01.11.2011 - 29.02.2012)
- Kidd, Emma
Create data demonstrating their efficacy and lay the foundation for an R&D facility to develop products independently (01.12.2011 - 17.06.2014)
- Maillard, Jean-Yves
Efficacy testing of sporicidal wipe (01.12.2011 - 11.12.2011)
- Maillard, Jean-Yves
Use of the ex-vivo test to evaluate the efficacy of antimicrobial topical formulations (05.12.2011 - 26.12.2011)
- Maillard, Jean-Yves
Enhancing the delivery of therapeutic cargo to cancer cells using cell penetrating peptides (01.01.2012 - 31.12.2014)
- Jones, Arwyn
Testing of the sporicidal activity of 3 new products against clostridium difficle (16.01.2012 - 31.01.2012)
- Maillard, Jean-Yves
Sublingual delivery (30.01.2012 - 31.03.2012)
- Heard, Charles
Testing of the new sporicidal activity of 3 new products against clostridium difficile (30.01.2012 - 29.04.2012)
- Maillard, Jean-Yves
Coded microwell array (01.02.2012 - 30.11.2012)
- Allender, Christopher
Controlling microbial infectivity in delivery of primary care (01.02.2012 - 31.08.2012)
- Heard, Charles
Mucus permeating nanoparticulate drug delivery systems (ALEXANDER) (01.03.2012 - 28.04.2016)
- Gumbleton, Mark
The involvement of lipid raft proteins in the processing of amyloid precursor protein (01.03.2012 - 30.06.2015)
- Kidd, Emma
Activity of antimicrobial surfaces using the JIS test (19.03.2012 - 22.03.2012)
- Maillard, Jean-Yves
Caneolin and cancer progression (01.04.2012 - 31.03.2015)
- Gumbleton, Mark
Characterisation of the human protective immune response to Antrax (01.04.2012 - 31.10.2016)
- Baillie, Les
Improving virucidal activity of surface disinfectant formulation (01.04.2012 - 28.02.2015)
- Maillard, Jean-Yves
Investigating whether anti-hormone-resistant cell lines acquire resistance to AZD8931 (01.04.2012 - 31.03.2014)
Investigation of mechanisms of antimicrobial resistance (01.04.2012 - 31.07.2012)
- Maillard, Jean-Yves
Testing of the sporiciadal activity of wipes against clostridium difficile (10.04.2012 - 13.04.2012)
- Maillard, Jean-Yves
Review formulation information on a novel phage therapeutic medicine for licensing purposes (01.05.2012 - 31.05.2012)
Testing of the efficacy of Byotrol wipes against two bacterial contaminants (14.05.2012 - 31.05.2012)
- Maillard, Jean-Yves
Investigating the role of efflux in Staphylococcus aureus (28.05.2012 - 27.07.2012)
- Maillard, Jean-Yves
Investigation into the factors effecting community pharmacists engagement with spontaneous reporting of adverse drug reactions (01.06.2012 - 31.03.2015)
- Barnes, Louise
Relative anti-oxidant and anti-inflammatory capacity in topically delivered extracts (01.06.2012 - 27.07.2012)
- Heard, Charles
In vitro and in vivo antiviral activity of novel compounds against influenza (01.07.2012 - 30.06.2014)
- Mcguigan, Christopher
Towards a magneto-optical sensor for sepsis (01.07.2012 - 26.08.2012)
- Allender, Christopher
ASTM standard submission for antimicrobial wipes (09.07.2012 - 21.12.2012)
- Maillard, Jean-Yves
Developing a methodology to evaluate the penetration forces required for capsules used in DPIs (09.07.2012 - 12.11.2012)
- Coulman, Sion
RAPPIDS: Rapid assay of pathogens with a portable immunosensor for diagnosing sepsis (16.07.2012 - 28.02.2015)
- Allender, Christopher
Enhancing opportunities for pharmacy student learning within a practice environment: A pilot of remote work-based learning (28.08.2012 - 31.08.2014)
- Smith, Mathew
Beta cell preservation via antigen-specific immunotherapy in type 1 diabetes: Enhanced epidermal antigen delivery systems (01.09.2012 - 31.05.2017)
- Birchall, James
Determining the effect of prolonged environmental incubation on the virulence of Bacillus Anthracis (01.09.2012 - 31.03.2013)
- Baillie, Les
Parenteral nutrition and drug stability (01.09.2012 - 31.08.2025)
- Cosslett, Allan
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (01.09.2012 - 14.09.2012)
- Maillard, Jean-Yves
Testing of the sporicidal activity of "Schulke" wipe against clostridium difficile (01.09.2012 - 14.09.2012)
- Maillard, Jean-Yves
Adsorbent carbons for the removal of biologically active toxins (ACROBAT1) (01.10.2012 - 30.09.2016)
- Baillie, Les
Cancer diagnosis: parallel sensing of prostate cancer biomarkers (PROSENSE) (01.10.2012 - 30.09.2016)
- Allender, Christopher
Microneedle skin penetration performance and effect (01.10.2012 - 31.12.2013)
- Birchall, James
Natural products analysis for pharmaceutical properties (01.10.2012 - 31.03.2013)
- Baillie, Les